Returning to the Scientific Workplace //
The COVID-19 virus has ushered in a new era of workplace design considerations. As of the publication date of this document, there is no effective virus treatment and no mass-produced vaccine. With the timetable for both unknown, it falls to businesses to work within the guidance offered by state and federal government, professional practice organizations, and international NGOs.
The purpose of this document is to understand how to best mitigate transmission risks in a Return to Work scenario with critical processes and personnel. A key aspect of our analysis was understanding how risk modalities for non-critical processes would affect the strategy for protecting critical processes.
August 04, 2020